This cGMP compliant production site started its operations in December 2006, in a surface area of 1.392 m2 arranged into two independent production rooms: one exclusively dedicated to biotherapeutic proteins production in prokaryote cells and the other to eukaryote host cells. The site houses from the MCB (Master Cell Bank) and WCB (Working Cell Bank) generation up to the process for obtaining the APIs, ready for its formulation and filling.